Skip Navigation

National HIV Testing Day 2012

National HIV Testing Day: Take the Test, Take Control


June 27th is National HIV Testing Day in the U.S., where nearly 1.2 million people are living with HIV and almost 1 in 5 don't know they’re infected. Getting tested is the first step to finding out if you have HIV. If you have HIV, getting medical care and taking medicines regularly helps you live a longer, healthier life and also lowers the chances of passing HIV on to others.

To raise awareness of National HIV Testing Day, the Editors of Clinical Infectious Diseases and The Journal of Infectious Diseases have highlighted recent, topical articles, which have been made freely available from June 27th for 14 days. Both journals are publications of the HIV Medicine Association and the Infectious Diseases Society of America.

Clinical Infectious Diseases articles:


Assessment of Population-Based HIV RNA Levels in a Rural East African Setting Using a Fingerprick-Based Blood Collection Method

Test-and-Treat in Los Angeles: A Mathematical Model of the Effects of Test-and-Treat for the Population of Men Who Have Sex With Men in Los Angeles County

Editorial Commentary: Children With HIV in Low-Prevalence Settings: Finding the Needle in a Haystack

Laboratory Diagnosis of HIV in Adults: A Review of Current Methods

Preexposure Prophylaxis for Adolescents and Young Adults at Risk for HIV Infection: Is an Ounce of Prevention Worth a Pound of Cure?

The Journal of Infectious Diseases articles:


Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Study

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection

Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

HIV Incidence Determination in the United States: A Multiassay Approach

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

HIV Testing Day 2013: Audio Interviews with HIV Experts


HIVMA Chair Michael Horberg, MD, MAS, FIDSA, and Carlos del Rio, MD, FIDSA, a member of HIVMA’s Board of Directors, provide more information on the importance of HIV testing in these brief audio interviews. Dr. del Rio’s interview is in Spanish.

IDSAHIVMAGlobal Health Policy